v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows From Operating Activities:    
Net Loss $ (122,107) $ (240,216)
Adjustments to reconcile net loss to net cash used in operations    
Depreciation and amortization 2,695 1,916
Amortization of right of use asset - operating 27,868 25,802
Amortization of right-of-use asset - financing 11,716 8,351
Changes in operating assets and liabilities:    
Accounts receivable (11,025) (2,267)
Receivable on sale of inventory asset 376 0
Prepaid expenses (5,865) 7,285
Inventory (115,475) 40,116
Accounts payable 2,831 (1,880)
Accrued interest – line of credit 22,766 13,086
Deferred revenue 50,000 0
Lease liability - operating (27,858) (19,734)
Net Cash Used for Operating Activities (164,078) (167,541)
Cash Flows From Investing Activities:    
Purchase of furniture & equipment (5,495) (13,199)
Loans to clinics (5,300) 0
Purchase of intangible assets 0 (3,604)
Net Used for Investing Activities (10,795) (16,803)
Cash Flows From Financing Activities:    
Payments made on lease liability - finance (11,716) (8,351)
Proceeds from sale of common stock 0 70,000
Line of credit 235,312 231,471
Net Cash Provided by Financing Activities 223,596 293,120
Net Increase in Cash 48,723 108,776
Cash at Beginning of Year 79,392 6,323
Cash at End of Period 128,115 115,099
Supplemental disclosure of cash flow information:    
Cash paid for interest 0 0
Cash paid for taxes 0 0
Supplemental disclosure of non-cash investing and financing activities:    
Shares to be issued for investment in non-consolidated business entity 0 79,500
Cancellation of shares $ 0 $ 25,495